Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.485 AUD | +1.04% | +8.99% | -14.91% |
May. 15 | Imricor Medical Systems, Inc. to Commence 2 Clinical Trials, VISABL-AFL and VISABL-VT | CI |
May. 15 | Transcript : Imricor Medical Systems, Inc. - Shareholder/Analyst Call |
Evolution of the average Target Price on Imricor Medical Systems, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- IMR Stock
- Consensus Imricor Medical Systems, Inc.